CVE:ERG 16611 (ERG.V) (ERG) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ERG Stock Alerts C$0.30 0.00 (0.00%) (As of 02/27/2018) Add Compare Share Share Today's RangeC$0.30▼C$0.3050-Day RangeC$0.30▼C$0.3052-Week RangeC$0.22▼C$0.30Volume2,000 shsAverage Volume83,684 shsMarket CapitalizationC$21.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get 16611 (ERG.V) alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About 16611 (ERG.V) Stock (CVE:ERG)Ergoresearch Ltd. operates in the healthcare sector. The Company manufactures and sells custom foot orthotics and general orthotics, and develops durable medical equipment for the orthopedic market. The Company is engaged in development of orthopedic solutions and products impacting pain management. The Company's products are non-invasive and non-toxic biomechanical devices, which feature patient benefits that are supported by clinical proof and scientific data. The Company designed and commercialized WebFit, a custom-fit orthotics manufacturing software program, and OdrA, an orthotic device. Its range of foot orthotics includes WebFit-Diabetes, WebFit-Gonosteoarthritis and WebFit. Its products also include podo-barometric sensor pads and scanners, and three dimensional (3d) scanner. The Company uses numerical control machine tools to manufacture its foot orthotics. It has approximately 10 laboratories.Read More ERG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ERG Stock News HeadlinesDecember 23, 2023 | reuters.comERG SpAOctober 13, 2023 | msn.comERG enters cobalt supply deal with EVelution in USApril 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.August 18, 2023 | bizjournals.comThe state of ERGsApril 11, 2023 | npr.orgMorning EditionApril 11, 2023 | npr.orgAll Things ConsideredApril 9, 2023 | npr.orgWeekend Edition SaturdayMarch 17, 2023 | forbes.comERG's: Are You Taking Advantage Of This Powerful Career Advancement Tool?April 28, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.February 24, 2023 | theguardian.comSunak ‘relaxed’ about DUP and Tory backlash over Northern Ireland dealSee More Headlines Receive ERG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 16611 (ERG.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolCVE:ERG CUSIPN/A CIKN/A Webwww.ergoresearch.com Phone+1-514-9313355FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares72,509,000Free FloatN/AMarket CapC$21.39 million OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesSylvain BoucherPresident, Chief Executive Officer, DirectorDominique BoudreauVice President - FinanceFrederic PetitVice President - OperationsDanielle BoucherVice- President of Clinique du Pied Equilibre, DirectorGilles LaporteDirectorCatherine ChamoutonIndependent DirectorMichel PierronIndependent DirectorFrancois TellierIndependent DirectorMore ExecutivesKey CompetitorsBluedrop Performance LearningCVE:BPLNesscap EnergyCVE:NCERio Novo GoldTSE:RN16610 (CGE.V)CVE:CGE102535 (CMM.V)CVE:CMMView All Competitors ERG Stock Analysis - Frequently Asked Questions How have ERG shares performed in 2024? 16611 (ERG.V)'s stock was trading at C$0.30 at the beginning of the year. Since then, ERG stock has increased by 0.0% and is now trading at C$0.30. View the best growth stocks for 2024 here. How do I buy shares of 16611 (ERG.V)? Shares of ERG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:ERG) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyUrgent Nvidia WarningAltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 16611 (ERG.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
